Drugs / engineered HB vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00939068 Background | Feb 2008 → Jul 2010 | chronic hepatitis B virus infection | Southeast University, China | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | engineered HB vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00939068 ↗ |
| Modality | Vaccine | “genetically engineered HB vaccine” NCT00939068 ↗ |